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Currently, endovascular repair is applicable to
approximately 60% of all infrarenal abdominal aortic
aneurysms (AAAs).1 The most common anatomic
reason for unsuitability for endovascular AAA repair
is lack of an adequate proximal implantation site as a
result of aneurysm origin in the pararenal aorta.1
Consequently, an increasing proportion of patients
who undergo conventional open repair will have
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Purpose: As endovascular stent graft repair of infrarenal abdominal aortic aneurysms
(AAAs) becomes more common, an increasing proportion of patients who undergo open
operation will have juxtarenal aneurysms (JR-AAAs), which necessitate suprarenal cross-
clamping, suprarenal aneurysms (SR-AAAs), which necessitate renal artery reconstruc-
tion, or aneurysms with associated renal artery occlusive disease (RAOD), which neces-
sitate repair. To determine the current results of the standard operative treatment of
these patterns of pararenal aortic aneurysms, we reviewed the outcome of 257 consecu-
tive patients who underwent operation for JR-AAAs (n = 122), SR-AAAs (n = 58), or
RAOD (n = 77).
Methods: The patients with SR-AAAs and RAOD were younger (67.5 ± 8.8 years) than
were the patients with JR-AAAs (70.5 ± 8.3 years), and more patients with RAOD were
women (43% vs 21% for JR-AAAs and SR-AAAs). The patient groups were similar in the
frequency of coronary artery and pulmonary disease and in most risk factors for ath-
erosclerosis, except hypertension, which was more common in the RAOD group.
Significantly more patients with RAOD had reduced renal function before surgery (51%
vs 23%). Supravisceral aortic crossclamping (above the superior mesenteric artery or the
celiac artery) was needed more often in patients with SR-AAAs (52% vs 39% for RAOD
and 17% for JR-AAAs). Seventeen patients (7%) had undergone a prior aortic recon-
struction. The most common renal reconstruction for SR-AAA was reimplantation (n =
37; 64%) or bypass grafting (n = 12; 21%) and for RAOD was transaortic renal
endarterectomy (n = 71; 92%). Mean AAA diameter was 6.7 ± 2.1 cm and was larger in
the JR-AAA (7.1 ± 2.1 cm) and SR-AAA (6.9 ± 2.1 cm) groups as compared with the
RAOD group (5.9 ± 1.7 cm).
Results: The overall mortality rate was 5.8% (n = 15) and was the same for all the groups.
The mortality rate correlated (P < .05) with hematologic complications (bleeding) and
postoperative visceral ischemia or infarction but not with aneurysm group or cardiac, pul-
monary, or renal complications. Renal ischemia duration averaged 31.6 ± 21.6 minutes
and was longer in the SR-AAA group (43.6 ± 38.9 minutes). Some postoperative renal
function loss occurred in 104 patients (40.5%), of whom 18 (7.0%) required dialysis. At
discharge or death, 24 patients (9.3%) still had no improvement in renal function and 11
of those patients (4.3%) remained on dialysis. Postoperative loss of renal function corre-
lated (P < .05) with preoperative abnormal renal function and duration of renal ischemia
but not with aneurysm type, crossclamp level, or type of renal reconstruction.
Conclusion: These results showed that pararenal AAA repair can be performed safely and
effectively. The outcomes for all three aneurysm types were similar, but there was an
increased risk of loss of renal function when preoperative renal function was abnormal.
These data provide a benchmark for expected treatment outcomes in patients with these
patterns of pararenal aortic aneurysmal disease that currently can only be managed with
open repair. (J Vasc Surg 1999;29:902-12.)
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juxtarenal aneurysms (JR-AAAs), which necessitate
suprarenal crossclamping, suprarenal aneurysms
(SR-AAAs), which necessitate renal artery recon-
struction, or juxtarenal aneurysms with associated
renal artery occlusive disease (RAOD), which neces-
sitate treatment.
Many large, referral-based2 and population-
based3-6 studies have established the outcome of
standard open operative repair of infrarenal aortic
aneurysms. In contrast, there is little available data
regarding the outcome of treatment of pararenal
aortic aneurysms. To determine the current results
of standard open operative management of patients
with the three patterns of pararenal aortic aneurys-
mal disease described previously, we reviewed the
outcome of 257 consecutive patients who under-
went treatment during the last two decades.
METHODS
All the patients who underwent open repair of an
AAA that necessitated the placement of the aortic
crossclamp proximal to the renal arteries were includ-
ed in the study. The aortic clamp was proximal to all
renal arteries in 201 patients (78.2%) in the study. We
eliminated all the patients with only aortic occlusive
disease, all the patients whose aortic aneurysms were
repaired with an infrarenal crossclamp, all the
patients with thoracoabdominal aneurysms (includ-
ing type IV), and all the patients with ruptured
aneurysms. The patients who underwent expeditious
pararenal AAA repair for onset of symptoms or for
rapid aneurysm growth were included if they were
hemodynamically stable (urgent). For patients who
underwent treatment between 1977 and 1987, data
were obtained by retrospective chart review. For
patients who underwent treatment between 1987
and 1997, data were prospectively collected (indica-
tion for operation, size of aneurysm, details of oper-
ation, crossclamp level, length of renal or visceral
ischemia, intraoperative and postoperative complica-
tions). These data were supplemented with retro-
spective chart review (demographic data, some
details of operation). Descriptive and comparative
statistical analysis was performed with analysis of vari-
ance and c 2 test where appropriate. Regression analy-
sis was performed to determine the factors that were
significantly related to mortality and renal morbidity
rates using only the data from cases performed dur-
ing the interval of prospective data collection.
Clinical material. The study group consisted of
122 patients who required suprarenal crossclamping
for repair of infrarenal aortic aneurysms (JR-AAA; Fig
1), 58 patients who required renal artery reconstruc-
tion to repair aneurysms extending above the renal
arteries (SR-AAA; Fig 2), and 77 patients with JR-
AAAs and associated symptomatic renal atherosclero-
sis (JR-AAA and RAOD; Fig 3). The mean patient
age was 68.9 ± 8.7 years, and the patients in the JR-
Fig 1. Typical appearance of juxtarenal abdominal aortic
aneurysm. There is no healthy segment of aorta below renal
arteries to allow deployment of endovascular device. Repair
requires suprarenal crossclamp, but proximal anastomosis
can be placed immediately below renal artery orifices.
Fig 2. Typical appearance of a suprarenal abdominal aor-
tic aneurysm. Repair requires reconstruction of involved
renal arteries.
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AAA group were older than the patients in the other
two groups (Table I). Most patients were men (n =
187; 73.8%), although the frequency of women was
significantly higher in the RAOD group than in the
other two groups. The patient groups were similar in
the frequency of most risk factors for atherosclerosis,
except for hypertension, which occurred significantly
more often in the RAOD group (Table I). Not sur-
prisingly, the patients in this group also had a signifi-
cantly higher incidence rate of impaired renal function
before surgery (serum creatinine level, ‡ 1.5 mg/dL;
Table II). The mean aneurysm diameter for all the
patients was 6.7 ± 2.1 cm. The RAOD group had sig-
nificantly smaller aneurysms than did the other two
groups (Table III).
Technique. The two most commonly used
operative approaches were the standard transperi-
toneal, infracolic aortic exposure (n = 192; 74.7%)
and medial visceral rotation (MVR; n = 42; 16.3%).
The retroperitoneal, thoracoretroperitoneal, and
thoracoabdominal approaches were used rarely. We
prefer the transabdominal approach because of the
improved exposure of the right renal artery and the
right iliac system, which facilitates repair of lesions 
of these vessels, and because of the lack of any clear-
ly documented advantage to the retroperitoneal
approach in prospective comparison studies. We
usually perform MVR from the left side, with a full-
length midline abdominal incision. The technique of
rotating the abdominal viscera from the left usually
includes all of the abdominal viscera (colon, pan-
creas, stomach, and spleen) but may be modified to
include only the colon—a partial or limited MVR,
depending on the extent of aortic exposure necessi-
tated. This mobilization plane can be developed
either anterior or posterior to the left kidney. MVR
was used to provide aortic exposure more often in
the SR-AAA group (Table III). Factors that might
lead to the selection of the MVR approach include
aneurysm size (particularly if the pararenal portion
of the aneurysm is large), patient size (large), reop-
erative procedures, and inflammatory aneurysms.
Infracolic aortic exposure was performed through a
standard full-length abdominal incision and
accounted for 77.1% of patients with JR-AAAs and
77.9% of patients with RAOD.
The key elements of adequate exposure of the
pararenal aorta include the management of the left
renal vein, the periaortic ganglionic tissue, and the
diaphragmatic crus. We routinely perform circum-
ferential dissection of the left renal vein from the
lumbar branch to the junction with the inferior vena
cava so that it can be widely displaced as needed.
This usually necessitates the sacrifice of the adrenal
vein and the gonadal vein. The superior mesenteric
artery and celiac axis (if needed) are exposed by exci-
sion of the dense autonomic ganglia from the
anterolateral surface of the aorta. Finally, we divide
the crus of the diaphragm in its tendinous portion
(median arcuate ligament) to open this periaortic
space and allow safe placement of the clamp. It is
usually necessary to divide this tendinous portion on
both sides of the aorta to completely open this
space.
Operative data. Most of the procedures per-
formed were elective (n = 221; 86.0%). The fre-
quency of urgent procedures was significantly lower
in the RAOD group in comparison with the other
two groups (Table III). In 31 cases (12.1%), the
patient had undergone either a prior aortic reopera-
tion (n = 17) or a prior nonvascular abdominal oper-
ation (n = 14). Among the patients with prior aortic
operations, 13 had para-anastomotic aneurysms, of
Fig 3. Typical appearance of juxtarenal abdominal aortic
aneurysm with associated severe renal artery occlusive dis-
ease (upper panel). Although not well shown on this
angiogram, computed tomography showed aneurysm to
extend to level of renal arteries. Postoperative appearance
after suprarenal crossclamp, transaortic renal endarterecto-
my, and infrarenal aortic grafting (lower panel).
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which 2 were clearly false aneurysms. Although
there were more reoperations in the SR-AAA group,
this difference was not significant. Suprarenal cross-
clamping was necessitated in 159 cases (61.9%) and
was most often used in the JR-AAA group. Supra-
superior mesenteric artery (SMA) clamping was used
in 48 cases (18.7%) and was most common in the
RAOD group. Supraceliac clamping was necessary
in 33 cases (12.8%) and was most common in the
SR-AAA group (Table III). Approximately 90% of
the patients underwent placement of either an aor-
toiliac graft (n = 127; 49.4%) or an aortic tube graft
(n = 103; 40.1%). All three groups were identical in
this regard. The most common method of renal
artery reconstruction in the SR-AAA group was
reimplantation (n = 37; 63.8%), and the most com-
mon method in the RAOD group was endarterecto-
my (n = 71; 92.2%). These differences were signifi-
cant but were consistent with the involvement of the
renal arteries by the aneurysm in the SR-AAA group
and the involvement of the renal arteries with occlu-
sive lesions in the RAOD group. Bilateral renal
reconstruction was performed in 55 cases (40.7%)
and was significantly more common in the RAOD
group. Unilateral renal artery repair was performed
in 66 cases (48.9%) and was much more common in
the SR-AAA group. Accessory renal arteries alone
necessitated reconstruction in 14 cases (10.3%).
Blood loss averaged 3.9 ± 4.6 L and did not vary
between groups. The duration of visceral ischemia
Table I. Patient demographics
JR-AAA (n = 122) SR-AAA (n = 58) AAA+RAOD (n = 77)
No. % No. % No. %
Age (years)* 70.5 ± 8.3 67.6 ± 8.2 67.5 ± 9.3
Gender
Men 97 79.5 46 79.3 44 57.1
Women† 25 20.5 12 20.7 33 42.9
Coronary artery disease 73 59.8 31 53.4 35 45.5
Diabetes 8 6.6 4 6.9 13 16.9
Smoking history 101 82.8 50 86.2 59 76.6
Hypertension† 75 61.5 36 62.1 70 90.9
JR-AAA, Juxtarenal abdominal aortic aneurysm; SR-AAA, suprarenal abdominal aortic aneurysm; AAA+RAOD, abdominal aortic
aneurysm with associated renal artery occlusive disease.
*P < .05, with analysis of variance.
†P < .05, with c 2 test.
Table II. Renal function data
JR-AAA (n = 122) SR-AAA (n = 58) AAA+RAOD (n = 77)
No. % No. % No. %
Renal function
On admission*
Abnormal 27 22.1 14 24.1 39 50.6
Postoperative
Transient Cr rise 38 31.1 22 37.9 18 23.4
Sustained Cr rise 9 7.3 7 12.1 8 10.4
New onset dialysis 7 5.7 5 8.6 6 7.8
Dialysis at discharge 1 0.8 3 5.2 3 3.9
At discharge*
Worse 15 12.3 16 27.6 13 16.9
Improved/unchanged 107 87.7 40 69.0 64 83.1
Serum creatinine level (mg/dL)
Preoperative† 1.3 ± 1.0 1.3 ± 0.5 1.9 ± 1.2
At discharge† 1.6 ± 1.4 1.9 ± 1.6 2.1 ± 1.7
JR-AAA, Juxtarenal abdominal aortic aneurysm; SR-AAA, suprarenal abdominal aortic aneurysm; AAA+RAOD, abdominal aortic
aneurysm with associated renal artery occlusive disease; Cr, creatinine level.
*P < .05, with c 2 test.
†P < .05, with analysis of variance.
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(for patients with supra-SMA or supraceliac clamps)
averaged 32.9 ± 12.9 minutes, and the average renal
ischemia time was 31.6 ± 21.6 minutes. Renal
ischemia duration was significantly longer for the
SR-AAA group in comparison with the other two
groups (Table III). The duration of renal ischemia
was 28.2 ± 8.4 minutes for renal endarterectomy,
60.9 ± 78.9 minutes for endarterectomy and reim-
plantation, 39.1 ± 17.1 minutes for reimplantation,
and 42.3 ± 39.2 minutes for patients who under-
went renal artery bypass grafting procedures. This
difference was significant in the comparison of
endarterectomy with reimplantation. Differences
between the other groups were not significant
because of the small number of times the other pro-
cedures were performed. The duration of renal
ischemia for patients who underwent bilateral repair
was 31.7 ± 11.5 minutes and for unilateral repair was
33.3 ± 22.6 minutes, which was not a statistically
significant difference.
RESULTS
The overall mortality rate was 5.8% (three intra-
operative and 12 postoperative deaths), and no differ-
ences were found between groups (Table IV). The
three intraoperative deaths and one of the postopera-
tive deaths were caused by the consequences of bleed-
ing. In addition, one patient died of a myocardial
infarction, one of a saddle pulmonary embolus, one of
sepsis probably related to endocarditis, and one of
progressive hepatic failure, related to underlying
hepatitis and not to ischemia. One patient died of
multisystem organ failure, which was related to previ-
ously undiagnosed metastatic lung cancer. The
remaining six patients all died of the consequences of
postoperative visceral ischemia/infarction, which
made this the most common cause of death in this
study group. Among those six patients, two had
undergone supraceliac crossclamping, three supra-
SMA crossclamping, and one suprarenal crossclamp-
ing. The involved segment of the gastrointestinal tract
Table III. Operative data
JR-AAA (n = 122) SR-AAA (n = 58) AAA+RAOD (n = 77)
No. % No. % No. %
Operation status
Urgent* 23 18.9 9 15.5 4 5.2
Redo 11 9.0 12 20.7 8 10.4
AAA size† (cms) 7.1 ± 2.1 6.9 ± 2.1 5.9 ± 1.7
Aortic graft type
Tube 48 39.3 23 39.7 32 41.6
Aortoiliac 62 50.8 29 50.0 36 46.8
Aortofemoral 7 5.7 5 8.6 9 11.7
Aortoiliofemoral 5 4.1 1 1.7 0 0.0
Renal reconstruction type*
Bypass grafting NA 12 20.7 3 3.9
Reimplantation NA 37 63.8 0 0.0
Endarterectomy NA 1 1.7 71 92.2
Renal arteries repaired*
Unilateral NA 32 55.2 34 44.2
Bilateral NA 15 25.9 40 51.9
Unilateral-accessory NA 8 13.8 3 3.9
Bilateral-accessory NA 3 5.2 0 0.0
Crossclamp level*
Supraceliac 14 11.5 17 29.3 2 2.6
Supra-SMA 7 5.8 28 22.4 28 36.4
Suprarenal 100 82.0 13 48.3 46 59.7
Approach
Standard infracolic 94 77.1 38 65.5 60 77.9
Medial visceral rotation 17 13.9 13 22.4 12 15.6
EBL (liters) 3.8 ± 4.7 4.5 ± 3.2 3.6 ± 5.5
Duration of ischemia (minutes)
Renal† 27.7 ± 10.6 43.6 ± 38.9 28.7 ± 9.7
Visceral 35.3 ± 14.6 35.3 ± 14.1 29.0 ± 9.0
JR-AAA, Juxtarenal abdominal aortic aneurysm; SR-AAA, suprarenal abdominal aortic aneurysm; AAA+RAOD, abdominal aortic
aneurysm with associated renal artery occlusive disease; AAA, abdominal aortic aneurysm; SMA, superior mesenteric artery; EBL, esti-
mated blood loss; NA, not applicable.
*P < .05, with c 2 test.
†P < .05, with analysis of variance.
patients (7.0%) required the institution of dialysis in
the postoperative period. Among the patients who
required dialysis, seven had undergone suprarenal
crossclamping, five had undergone supra-SMA cross-
clamping, and six had undergone supraceliac cross-
clamping. Of note, the average duration of renal
ischemia for the patients who required dialysis was
42.1 ± 32.8 minutes, which was significantly longer
than in the patients who did not require dialysis
(30.7 ± 20.3 minutes). The patients who required
dialysis had an average preoperative creatinine level of
1.8 ± 1.2 mg/dL, which was not significantly differ-
ent from the patients who did not require dialysis
(1.5 ± 1.0 mg/dL). Seven of those 18 patients no
longer required dialysis at discharge—three patients
had normalized to their preoperative baseline creati-
nine level, and four patients had persistent elevation
of the creatinine level. The remaining 11 patients
continued to require dialysis at discharge (n = 7) or
at death (n = 4), which yielded an incidence rate 
of new “permanent” dialysis of 4.3%. Eighty-six
patients (33.5%) had a rise in creatinine level but did
not require dialysis. At discharge, 55 of those patients
had returned to the baseline creatinine level and 29
had not (no data in two patients). At discharge, the
creatinine level had declined from its postoperative
maximum in 16 of those 29 patients but stayed with-
in 0.5 mg/dL of the postoperative maximum in the
remaining 13 patients. Thus, of all 104 patients with
some postoperative creatinine level rise, at discharge
or death, 58 (55.8%) had levels that had returned to
baseline (including three who had transiently
required dialysis), 20 (19.2%) had levels that were
improving but had not reached baseline (including
four who had transiently required dialysis), 13
(12.5%) had levels that remained worse with no clear
improvement, and 11 (10.6%) remained on dialysis.
There were no differences between the three treat-
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was the colon in two patients, the small bowel in one,
and both in the remaining three. The underlying cause
was embolization in four cases and thrombosis in one
and was uncertain in the final patient. Regression
analysis results of perioperative factors indicated 
that intraoperative bleeding, postoperative visceral
ischemia/infarction, and postoperative hematologic
complications (bleeding) were significantly correlated
with mortality rate. Of note, type of pararenal
aneurysm, crossclamp level, myocardial infarction,
new-onset dialysis, and pulmonary complications
were not correlated with mortality rate.
The overall frequency and pattern of complica-
tions in this patient group was typical for complex
aortic reconstructions. The most common postoper-
ative complications were pulmonary complications (n
= 37; 14.4%; Table IV), and the most frequent pul-
monary complications were pneumonia (n = 15) or
respiratory insufficiency that necessitated prolonged
intubation (n = 19). Infectious complications were
second in frequency (n = 36; 14.0%). The most fre-
quent site of infection was the lungs (pneumonia, n
= 15), followed by intra-abdominal infections related
to visceral ischemia or infarction (n = 7), urinary tract
(n = 6), and wound (n = 6). Cardiac complications
occurred in 13.2% of the patients (n = 34) and were
usually arrhythmias (n = 16) or myocardial infarction
(n = 15). Only one perioperative myocardial infarc-
tion was fatal. One of the other 14 myocardial infarc-
tions occurred in a patient who died but was not the
cause of the death. Vascular complications developed
in 19 patients (7.4%) and included lower extremity
thrombosis/embolization/compartment syndrome
(n = 10), visceral artery thrombosis (n = 1), renal
artery bypass graft thrombosis (n = 1), and deep
venous thrombosis (n = 3). Twenty-one patients
underwent reoperations (8.2%), which were most
commonly for lower extremity arterial thrombosis/
embolization/compartment syndrome (n = 7) or for
visceral ischemia/infarction (n = 6). Wound compli-
cations occurred in 10 patients (3.8%) and included
infection (n = 6) and dehiscence (n = 4). Three of
those cases necessitated a reoperation for reclosure.
Neurologic complications occurred in 16 patients
(6.2%) and included five strokes and three transient
ischemic attacks. Paraplegia developed in only one
patient (0.3%). There were no differences between
the groups in the frequency of any of these compli-
cations.
A significant postoperative elevation of serum
creatinine level (a creatinine level rise of ‡ 0.5 mg/dL
in comparison with the admission level) occurred in
104 patients (n = 40.5%; Table II). Eighteen of those
Table IV. Mortality and morbidity rates
No. %
Deaths 15 5.8
Complications
Respiratory insufficiency 19 7.4
Pneumonia 15 5.8
Myocardial infarction 15 5.8
Stroke 5 1.9
Paraplegia 1 0.4
Visceral ischemia/infarction 7 2.7
Lower limb embolization/thrombosis 9 3.5
Requiring reoperation 7 2.7
Wound infection 5 1.9
Wound dehiscence 4 1.6
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ment groups in the frequency of postoperative renal
insufficiency or of new-onset dialysis. Persistent ele-
vation of the serum creatinine level at discharge
occurred more often in the SR-AAA group and
showed a significant difference in comparison with
the JR-AAA group but not in comparison with the
RAOD group (Table II). When regression analysis
was used to identify factors that correlated with renal
morbidity rate, only preoperative renal function sta-
tus and duration of renal ischemia were significant.
Neither crossclamp level, type of renal reconstruc-
tion, nor any other preoperative risk factor correlated
with loss of renal function or necessity for dialysis.
DISCUSSION
In comparison with infrarenal aortic aneurysm
repair, pararenal aortic aneurysm repair is character-
ized by more extensive mobilization of the viscera to
provide extended proximal exposure of the abdomi-
nal aorta, a more proximal level of aortic crossclamp-
ing, and an obligatory period of renal ischemia. As a
result, there is an increased risk of death associated
with the greater physiologic and cardiac stress of the
procedure and an increased risk of loss of renal func-
tion associated with the length of renal ischemia.
Thus, the mortality rate and the renal failure rate are
the major concerns about the safety of operation for
these patterns of aortic aneurysmal disease.
Ernst2 pooled data from several referral-based
studies and reported an overall mortality rate of 3.5%
(range, 1.5% to 5.1%) for routine repair of nonrup-
tured infrarenal AAAs. Our own mortality rate for
the repair of infrarenal aortic aneurysms in the refer-
ral population at the University of California–San
Table V. Literature summary
No. AAA type* Crossclamp Mortality Baseline Transient New-onset Elevated Cr 
Study of cases (no.) level rate elevated Cr Cr rise dialysis at discharge
Crawford et al7 1986 101 JR 88 SC 93 7.9% 18.8% 15.8% 7.9% ND
SR 0 SSMA 0
RAOD 13 SR 8
Qvarfordt8 et al 1986 77 JR 22 SC 13 1.3% 54.5% 23.0% 2.5% 13.0%
SR 24 SSMA 17
RAOD 31 SR 45
Green et al9 1989† 52 JR 29 SC 30 15.4% ND ND 11.5% ND
SR ? SSMA 0
RAOD ? SR 22
Poulias et al10 1992 38 JR 32 SC 0 5.3% 15.8% 23.7% 13.2% 13.2%
SR 0 SSMA 0
RAOD 6 SR 38
Breckwoldt et al12 1992§ 39 unclear SC 8 2.6% ND 28.2% 2.6% 12.8%
SSMA 2
SR 25
Allen et al11 1993( 65 JR 24 SC 27 1.5% 20.0% 12.3% 3.1% 3.1%
SR 15 SSMA 12
RAOD 7 SR 26
Nypaver et al13 1993 53 JR 41 SC 21 3.8% 17.0% 22.6% 5.7% 7.5%
SR 6 SSMA 4
RAOD 6 SR 28
Schneider14 et al 1997 23 JR 23 SC 23 0.0% ND 26.1% 0.0% 0.0%
SR 0 SSMA 0
RAOD 0 SR 0
Faggioli et al15 1998¶ 50 JR 39 SC 8 7.0% 10.0% ND ND 0.0%
SR 6 SSMA 0 (elective only)
RAOD 5 SR 42
Present study 257 JR 122 SC 33 5.8% 31.1% 30.4% 7.0% 10.5%
SR 58 SSMA 48
RAOD 77 SR 174
AAA, Abdominal aortic aneurysm; Cr, creatinine level; JR, juxtarenal; SR, suprarenal; RAOD, renal artery occlusive disease; SC,
supraceliac; SSMA, supra-superior mesenteric artery; ND, no clear data.
*Best estimate of categorization University of California–San Francisco pararenal abdominal aortic aneurysm groups.
†Very difficult to put the data in this study into this format; also suprarenal clamp group contained 11 patients who initially had an
infrarenal clamp.
§Only 33 abdominal aortic aneurysms matched University of California–San Francisco categories.
iOnly 46 abdominal aortic aneurysms matched University of California–San Francisco categories.
¶Includes seven ruptured pararenal abdominal aortic aneurysms.
Francisco during the last 8 years is 3.1%. In general,
the mortality rates for AAA repair reported from
population-based studies are higher, ranging from
4.6% to 7.6%. Katz et al3 reported a mortality rate of
7.5% for AAA repair in the state of Michigan from
1980 to 1990, which was remarkably similar to the
results of a recent review of statewide aneurysm
repair data from California, which cited a mortality
rate of 7.6%.4 The Veterans Affairs Aneurysm
Detection and Management study reported a periop-
erative mortality rate of 4.9%.5 Johnston and Scobie6
reported a mortality rate of 4.8% in their Canadian
population study. There are fewer studies that report-
ed results of pararenal aortic aneurysm repair, and all
of these studies are referral based. The original series
by Crawford et al7 reported a mortality rate of 7.9%,
which was mostly attributed to the consequences of
renal failure. Our earlier series8 of 77 patients had a
mortality rate of 1.3%. Since then, seven additional
series have been published, with mortality rates vary-
ing from 0% to 10%.9-15 Importantly, most of these
series are heavily weighted toward patients with JR-
AAAs and usually include few patients with SR-AAAs
and fewer patients with JR-AAAs and associated
RAOD (Table V). The 5.8% mortality rate that was
seen in this series of patients therefore compares
favorably with published rates both for routine infra-
renal aneurysm repair and for pararenal aneurysm
repair and is not significantly different from our ear-
lier report.8
It has generally been assumed that the increased
risk of death associated with pararenal aneurysm
repair relates to the cardiac effects of these longer pro-
cedures and the more proximal aortic crossclamp
level. This was not the case in our patient group, in
which myocardial infarction caused only one of 15
deaths (6.7%). In contrast, myocardial infarction
accounted for 32% of the deaths (eight of 25) in the
other published series (using only the data from
patients with matching types of pararenal aneurysms).
Obviously, careful preoperative cardiac assessment
and meticulous intraoperative anesthetic management
are important in the reduction of the cardiac impact
of these procedures. Of note, we selectively obtain
preoperative cardiologic consultation and preopera-
tive stress testing and also selectively use intraopera-
tive pulmonary artery catheter monitoring and trans-
esophageal echocardiography. During surgery, vasodi-
lation before the placement of the aortic crossclamp is
used routinely. An additional factor that may have
reduced the rate of fatal myocardial infarctions in 
this study is the limited use of supraceliac crossclamp-
ing (13% of cases). In many of the other series of
pararenal aneurysm repair, supraceliac crossclamping
was used predominantly or exclusively.7,9,11,13,14 The
altered cardiac physiology that results from temporary
supraceliac aortic occlusion has been well defined.9,16
The avoidance of these changes when feasible seems
likely to result in reduced rate and severity of cardiac
morbidity.
Although the overall incidence rate of visceral
ischemia in this study was low (2.7%) and not signifi-
cantly different from that reported in other series of
pararenal aneurysm repair (13 of 672; 1.9%)7,9-15 or
from that in series of infrarenal aneurysm repair (0.2%
to 10%),17 the predominance of visceral ischemia or
infarction as a cause of death in our patients (6 of 15;
40%) was unexpected. Intraoperative mesenteric
embolization occurred in at least four and probably in
five of these patients. In the remaining patient, under-
estimation of the severity of occlusive lesions in the
SMA and celiac axis resulted in postoperative throm-
bosis. Among the deaths reported in other pararenal
aneurysm series, only three (12.0% of all deaths) were
attributed to visceral ischemia/infarction.
Some authors have expressed concern about the
possibility of embolization associated with the mobi-
lization and crossclamping of the pararenal or paravis-
ceral aorta (particularly with the suprarenal aortic
clamp).9,13 These authors and others have recom-
mended avoiding the paravisceral aorta entirely and
routinely using the supraceliac aorta for clamp place-
ment, which is a safer technique in their opinion
because of the less frequent involvement of this area
with significant atherosclerosis and the greater ease of
mobilization when compared to the paravisceral
aorta.8,9,13,14 The paper by Green et al9 is most often
cited as establishing the safety of placing the aortic
clamp in the supraceliac location. However, in this
study, the authors make a methodologic error in their
analysis of the patients in whom complications of a
failed infrarenal crossclamp developed, a group they
refer to as “below-above renals.” Green et al9 includ-
ed those patients in the suprarenal crossclamp group
when, in fact, they should have been included in the
infrarenal crossclamp group because they all initially
had undergone infrarenal crossclamping and the
clamp was only placed above the renal arteries when
problems occurred. The reported significant differ-
ence between the suprarenal clamp group and the
supraceliac clamp group for the end points of
atheroembolization, visceral ischemia, and death only
exists if the patients with “below-above renals” under-
go analysis (incorrectly) in the SR-AAA group. If the
patients with “below-above renals” undergo analysis
(correctly) in the infrarenal group, then there is no
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difference between the supraceliac clamp group and
the suprarenal clamp group in the incidence rates of
atheroembolization, visceral ischemia, or death.
(Interestingly, this paper is also cited as showing that
patients who have undergone supraceliac clamping
have a lower incidence rate of renal failure that neces-
sitates dialysis. However, regardless of how the
patients with “below-above renals” undergo analysis,
the only significant difference in the postoperative
dialysis rate occurred between the infrarenal cross-
clamp group and the suprarenal crossclamp group,
not between the supraceliac crossclamp group and the
suprarenal crossclamp group). 
The data from this present study suggest exactly
the opposite relationship between crossclamp level and
atheroembolization or visceral ischemia: the rate of vis-
ceral embolization was lowest in the suprarenal clamp
group (0.6%) and significantly higher in both the
supra-SMA clamp group (6.3%) and the supraceliac
clamp group (9.1%). Although these differences 
are significant with univariate analysis, multivariate
regression analysis showed no significant correlation
between crossclamp level and the development of vis-
ceral ischemia/infarction. Although it is possible that
this lack of correlation relates to the low incidence rate
of visceral ischemia in this study (type 2 error), other
investigators have also reported the same lack of cor-
relation between outcome and crossclamp level in
patients who have undergone pararenal aneurysm
repair.11 Furthermore, if one crudely pools all the data
from the published studies of pararenal aneurysm
repair, there is no significant difference between the
incidence rate of visceral ischemia and the three cross-
clamp levels (supraceliac clamp, 243 with three
episodes of visceral ischemia; supra-SMA clamp, 66
with three episodes of visceral ischemia; and suprarenal
clamp, 363 with seven episodes of visceral ischemia).
We believe that experience with exposure of the
pararenal and paravisceral aorta and knowledge of its
key elements, more so than the actual crossclamp
position, play a major role in the reduction of com-
plications. Accurate preoperative assessment of the
amount of disease in the aorta at the planned level of
crossclamping, correct selection of the optimal
crossclamp level, selection of the optimal approach
for the needed exposure, and following the proper
clamping and declamping sequence for the aorta and
visceral branches are all important factors in reduc-
ing the incidence rate of atheroembolization. In fact,
probably the most important message from the
paper by Green et al,9 and one that seems to be
almost completely overlooked, is that it is the patient
whose crossclamp level is incorrectly chosen who has
the highest likelihood of significant complications,
usually atheroembolic and often fatal.
The renal morbidity rate associated with pararenal
aneurysm repair is the second important outcome end
point. In this study, the frequency of some postopera-
tive renal dysfunction was 40.5%. Although this rate is
higher than that observed in any other series of
pararenal aneurysm repair (Table V), it is instructive to
note that Johnston’s17 1989 review of the morbidity
and mortality rates after infrarenal AAA repair report-
ed up to a 16% probability rate of renal damage for
infrarenal AAA repair with an infrarenal crossclamp
and up to a 69% probability rate of renal damage if a
suprarenal clamp was needed during infrarenal AAA
repair. In addition, the 31% incidence rate of abnormal
baseline renal function in our patients is also the high-
est reported rate and preoperative renal function status
was correlated significantly with postoperative loss of
renal function in our study. Allen et al11 also reported
that preoperative renal insufficiency was a significant
risk factor for postoperative decline in renal function,
although Breckwoldt et al12 and Nypaver et al13
reported no correlation. The rate of temporary or per-
manent dialysis in this series (7.0%) and the rate of
some renal function impairment at discharge or death
(10.5%) are within the range observed by others and
are not significantly different from our earlier report8
(Table V). The fact that approximately 75% of the
patients who had some renal function loss in the post-
operative period had improved or returned to baseline
before discharge strongly suggests that the mechanism
is acute tubular necrosis related to the duration of
crossclamp-induced renal ischemia, other perioperative
physiologic changes altering renal perfusion, or both
and is not related to atheroembolization. This high
rate of renal dysfunction from acute tubular necrosis is
in contrast to the observations of other series that the
most common mechanism for postoperative renal fail-
ure is atheroembolization.6,9,18 For the 25% of
patients who had persistent loss of renal function at
discharge, atheroembolization is a possible explana-
tion. In both groups of patients, reassessment of their
renal function during follow-up examination is impor-
tant in defining the mechanism of the postoperative
change in renal function.
Not surprisingly, duration of renal ischemia also
correlated with an increased risk of loss of renal
function after surgery. There are several steps that
can be taken to minimize the duration of renal
ischemia. First, the aortic clamp is always posi-
tioned to preserve flow into some renal parenchy-
ma if that is possible. Unfortunately, this was
anatomically possible in only 22% of the patients in
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this group. Second, the aortic clamp is reposi-
tioned onto the prosthetic graft as soon as the
proximal anastomosis is completed and hemostatic.
Third, for SR-AAA, whenever possible a beveled
proximal aortic anastomosis is performed, incorpo-
rating one of the renal artery orifices. This restores
perfusion to one of the kidneys expeditiously and
leaves only one renal artery to be reimplanted or
grafted. Fourth, for the patients with RAOD,
transaortic endarterectomy is the most expeditious
method to treat occlusive disease affecting both
kidneys, particularly when there are multiple renal
arteries.
Some authors have recommended hypothermic
renal perfusion, which extends the ischemia toler-
ance of the renal parenchyma by reducing its meta-
bolic rate, as a protective mechanism.11 We have
used cold perfusion selectively (27% of this group).
Because the crossclamp time is short in the JR-AAA
group, we rarely use cold perfusion in this group.
Because we tend to treat occlusive renal artery
lesions with endarterectomy, which treats all renal
arteries simultaneously, we rarely use cold perfusion
in the RAOD group. We more commonly use cold
perfusion in the patients with SR-AAAs, in whom
the duration of renal ischemia is usually longer, par-
ticularly for the left kidney. In some published
pararenal aneurysm series, cold perfusion was not
used at all12,14 and in others it was selectively
used11,13 on the basis of the expected length of renal
ischemia and preoperative renal function status. We
routinely induce a diuresis, usually with mannitol,
before aortic crossclamping. We also believe it is wise
to avoid any contrast studies in the 24 to 48 hours
before the planned operative procedure. Although
we do not have complete data regarding the arteri-
ogram-operation interval for this group of patients,
most of these patients completed their workup
before referral to the University of California–San
Francisco Vascular Center.
CONCLUSION
With appropriate preoperative patient assessment,
optimal selection of operative strategy, careful intra-
operative anesthetic management, meticulous atten-
tion to operative technical detail, and skilled postop-
erative management, pararenal aortic aneurysms can
be safely and effectively treated. Perioperative mor-
bidity and mortality rates approach those of standard
infrarenal aortic aneurysm repair, with the exception
of an increased renal morbidity rate. The outcomes
for the three patterns of pararenal aortic aneurysmal
disease are similar, but preoperative abnormal renal
function, particularly in combination with a pro-
longed interval of renal ischemia, is associated with
an increased risk of further loss of renal function,
which is often, but not always, transient and
reversible. These data provide a reference point for
expected treatment outcomes in patients with these
patterns of pararenal aortic aneurysmal disease that
currently can only be managed with open repair.
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